Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Return on Capital Employed: 2011-2025

Historic Return on Capital Employed for Adma Biologics (ADMA) over the last 10 years, with Sep 2025 value amounting to 0.33%.

  • Adma Biologics' Return on Capital Employed fell 1.00% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of 0.39% for FY2024, which is 32.00% up from last year.
  • As of Q3 2025, Adma Biologics' Return on Capital Employed stood at 0.33%, which was down 2.75% from 0.34% recorded in Q2 2025.
  • Over the past 5 years, Adma Biologics' Return on Capital Employed peaked at 0.36% during Q4 2024, and registered a low of -0.32% during Q1 2021.
  • Its 3-year average for Return on Capital Employed is 0.19%, with a median of 0.26% in 2024.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first dropped by 7bps in 2021, then surged by 33bps in 2024.
  • Adma Biologics' Return on Capital Employed (Quarterly) stood at -0.26% in 2021, then climbed by 12bps to -0.14% in 2022, then rose by 21bps to 0.07% in 2023, then climbed by 29bps to 0.36% in 2024, then dropped by 1bps to 0.33% in 2025.
  • Its last three reported values are 0.33% in Q3 2025, 0.34% for Q2 2025, and 0.34% during Q1 2025.